UCP2 gene variants were found to be associated with reduced insulin sensitivity and obesity [13], metabolic syndrome [14], prediabetes and type 2 diabetes mellitus [15,16], hypertension [17], coronary artery disease [18], and stroke outcome [19]. Here, UCP2 is linked to hypertensive disorder.